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P-type ATPases of subfamily IV (P4-ATPases) constitute a
major group of phospholipid flippases that form heteromeric
complexes with members of the Cdc50 (cell division control
50) protein family. Some P4-ATPases interact specifically with
only one β-subunit isoform, whereas others are promiscuous
and can interact with several isoforms. In the present study,
we used a site-directed mutagenesis approach to assess the
role of post-translational modifications at the plant ALIS5 β-
subunit ectodomain in the functionality of the promiscuous plant
P4-ATPase ALA2. We identified two N-glycosylated residues,
Asn181 and Asn231. Whereas mutation of Asn231 seems to have
a small effect on P4-ATPase complex formation, mutation of
evolutionarily conserved Asn181 disrupts interaction between the
two subunits. Of the four cysteine residues located in the ALIS5
ectodomain, mutation of Cys86 and Cys107 compromises complex
association, but the mutant β-subunits still promote complex
trafficking and activity to some extent. In contrast, disruption
of a conserved disulfide bond between Cys158 and Cys172 has no
effect on the P4-ATPase complex. Our results demonstrate that
post-translational modifications in the β-subunit have different
functional roles in different organisms, which may be related to
the promiscuity of the P4-ATPase.
Key words: Arabidopsis thaliana, Cdc50 ectodomain, disulfide
bond, flippase, N-glycosylation.
INTRODUCTION
The P-type ATPase superfamily comprises a large number of
primary transmembrane-spanning transporters that share the
common characteristic of forming a phosphorylated intermediate
during their catalytic cycle [1]. P-type ATPases are divided
into five subfamilies according to their transport specificity
[2]. Members of the P1, P2 and P3 subfamilies transport
monovalent or divalent cations across cellular membranes. In
contrast, P4-ATPases are phospholipid transporters necessary to
create and maintain an asymmetrical distribution of phospholipids
in eukaryotic plasma membranes and membranes of the late
secretory and endocytic compartments [3]. Finally, P5-ATPases
are eukaryotic proteins with no assigned specificity, although a
human member of this family has been suggested to transport
polyamines [4]. Within the large and heterogeneous P-type
ATPase superfamily, only the P2C- and P4-ATPase subfamilies
are known to require a heterodimeric interaction with a β-
subunit [5,6]. Although P2C- and P4-ATPase β-subunits do not
share sequence similarity, they are alike in terms of polypeptide
chain length and membrane topology [5,6], and they seem to
fulfil similar functional roles, being required for maturation, ER
(endoplasmic reticulum) exit, subcellular trafficking and catalytic
activity of the P-type ATPase [6–16].
The β-subunits of P4-ATPases belong to the evolutionarily
conserved family of the Cdc50 (cell division control 50) proteins
[17,18]. The number of Cdc50 isoforms appears to differ between
organisms. Whereas only one isoform has been described in
Caenorhabditis elegans [17], three isoforms are present in yeast,
humans and the unicellular parasite Leishmania, and up to five
exist in plants. Some P4-ATPases interact specifically with only
one β-subunit isoform, whereas others are more promiscuous
and can interact with several isoforms. Monogamous P4-ATPases
have been described in unicellular organisms such as yeast or
Leishmania [9,11,19] and also in humans, where at least one P4-
ATPase, ATP8A2 expressed in neurons and rod outer segments
of the eye, interacts only with CDC50a [20,21]. In contrast,
other human P4-ATPases, such as ATP8B1 and ATP8B2, are
promiscuous and can interact with both CDC50a and CDC50b
[7,20]. This also seems to be the case for plant P4-ATPases. In
the model plant Arabidopsis thaliana, all P4-ATPases analysed
to date can make use of any of three β-subunits for ER exit and
functionality [10,22–24].
Cdc50 proteins are a bit smaller than 400 amino acids in
length and present two transmembrane spans separated by a large
exoplasmic loop, which contains two to four glycosylation sites
and is stabilized by disulfide bonds [7,18,21,25–27]. The role
of post-translational modification of the β-subunit in P4-ATPase
functionality is poorly studied. In yeast, disruption of each of two
disulfide bonds in the ectodomain of the P4-ATPase β-subunit
Lem3p has opposite effects on trafficking of the complex and
lipid translocation [17]. Mutation of any of the cysteine residues
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involved in formation of the first disulfide bond (closest to the N-
terminus) affects interaction between complex subunits, but does
not have an effect on lipid transport at the plasma membrane. In
contrast, disruption of the second disulfide bond, formed between
highly conserved cysteine residues, results in a reduced lipid-
translocating activity, but does not seem to affect the strength of
the P4-ATPase–β-subunit interaction. Whether this is also true
for P4-ATPases in other organisms is not known. Studies on
the effect of β-subunit N-glycosylation on P4-ATPase complex
functionality in humans and parasites show contradictory results,
suggesting specific organismal differences. In the unicellular
parasite Leishmania infantum, N-glycosylation of a single specific
residue (Asn176), evolutionarily conserved among parasites, yeast
and humans, affects lipid translocation but not trafficking of the
P4-ATPase–β-subunit complex [27]. In contrast, mutation of the
same N-glycosylated residue in a mammalian Cdc50 protein
reduces expression levels of the P4-ATPase complex, but does
not affect its ATPase activity [21]. In agreement with this, a yeast
P4-ATPase does not seem to require full glycosylation of its β-
subunit to form a phosphorylated intermediate during the catalytic
cycle [16], but the effect of this post-translational modification on
protein stability or complex assembly and trafficking in yeast
remains to be elucidated.
One common characteristic of all P4-ATPase–β-subunit
complexes analysed to date is that they are formed by a
monogamous P4-ATPase interacting only with a specific β-
subunit. In the present study, we investigated the effects of
post-translational modifications at the β-subunit ectodomain on
the functionality of a promiscuous P4-ATPase. As a model,
we used the complex formed between the A. thaliana P4-
ATPase ALA2 and the β-subunit ALIS5, which has been
characterized previously as a pre-vacuolar compartment PS
(phosphatidylserine)-specific transporter [24]. Using a site-
directed mutagenesis approach, we mapped residues subjected
to N-glycosylation and involved in disulfide bond formation in
the ectodomain of ALIS5, and assessed their role in P4-ATPase
expression, complex formation, trafficking and functionality.
In contrast with other organisms, elimination of a conserved
N-glycosylation site in ALIS5 affects complex formation,
whereas elimination of a conserved disulfide bond does not
have any consequence for the lipid-translocating activity of
the complex. Our results demonstrate that conserved post-
translational modifications have different functional roles in
different organisms, which may be related to the promiscuous
nature of the P4-ATPase.
MATERIALS AND METHODS
Yeast strain and growth conditions
Functional complementation and lipid translocation assays were
carried out employing Saccharomyces cerevisiae mutant strain
ZHY709 (MATα his3 leu2 ura3 met15 dnf1 dnf2 drs2::LEU2)
[28]. Yeast cells were transformed using the lithium acetate
method [29] and grown in rich synthetic medium containing
0.7% (w/v) yeast nitrogen base, 2% (w/v) glucose (SD, synthetic
glucose) or galactose (SG, synthetic galactose), supplemented
with 1.4 g/l yeast synthetic dropout medium lacking histidine
and uracil or 1.92 g/l yeast synthetic dropout medium lacking
uracil (Sigma–Aldrich). When appropriate, standard rich YPG
medium [2% (w/v) peptone, 1% (w/v) yeast extract and 2%
(w/v) galactose] was used. For solid medium, 2% (w/v) agar was
added. For complementation assays, fresh yeast transformants
were incubated in liquid SG medium for 4 h at 30 ◦C with shaking
at 150 rev./min. For complementation tests of N-glycosylation
mutants, transformants were diluted in water to a D600 of 0.1, 0.01,
and 0.001. Drops (5 μl) were spotted on to plates. When stated, SG
medium was supplemented with papuamide A (Lynsey Huxham,
Flintbox) or duramycin (Sigma–Aldrich) to final concentrations of
0.05 μg/ml and 1.6 μM respectively. For complementation tests
of cysteine mutants, transformants were diluted with water to a
D600 of 0.1 and 4 μl drops were then spotted on to SD or SG
control plates or on to SG gradient plates containing maximum
concentrations of 0.35 μg/ml papuamide A or 2 μM duramycin.
Gradient plates were prepared as described previously [30] except
that they were incubated for 2 days before use to allow vertical
diffusion of the toxin. All spotted plates were incubated at 30 ◦C
for 3–4 days and experiments were repeated independently at least
three times.
DNA cloning
Primers and plasmids used are listed in Supplementary Tables S1,
S2 and S3. All PCRs were carried out using Phusion® High-
Fidelity DNA Polymerase (New England Biolabs) according
to the manufacturer’s instructions. To create a FLAG-tagged
ALIS5 for yeast expression studies, a modified version of
pRS423-GAL [31] was constructed. The pRS423-GAL plasmid
was used as a template in a PCR using primers oli2761 and
oli2763. This generated a GAL1-10 promoter fragment flanked
by BamHI and EcoRI sites, and containing a FLAG tag at
the GAL1 side. The PCR fragment was cloned into pCRTM4
Blunt-TOPO® using the Zero Blunt® TOPO® PCR Cloning
Kit for Sequencing (Invitrogen), to generate plasmid pMP3072.
The FLAG-containing GAL1-10 fragment was excised from this
plasmid with EcoRI and BamHI and ligated to pRS423-GAL
digested with the same enzymes, rendering pMP3074. pMP3119
was produced by transferring the full-length ALIS5 cDNA from
pMP2022 [10] to pMP3074 after BamHI/SacI digestion. FLAG-
tagged ALIS5 was excised from pMP3119 with AgeI and SacI
and ligated to pRS426-GAL [31] cut with the same enzymes,
rendering a yeast multicopy plasmid containing a FLAG-tagged
version of ALIS5 and a URA3 cassette (pMP3836).
All alis5 mutants were generated through a homologous
recombination strategy in which a number of overlapping PCR
fragments were transformed into yeast strain ZHY709 together
with a linearized plasmid. In most cases, two overlapping
fragments containing the desired mutation(s) were generated
by PCR amplification using the templates and primers listed
in Supplementary Table S3. The fragments contained a 20-nt
overlap with the sequence of either the GAL1-10 promoter or
the T3 annealing region of yeast plasmid pRS426-GAL. In the
case of double or quadruple cysteine mutants, three overlapping
fragments were generated. Aliquots of 20 μl of each PCR product
were transformed without purification into yeast strain ZHY709
together with plasmid pRS426-GAL linearized with BamHI.
Transformed cells (three to five colonies) were grown in 6 ml
of SD medium for 24 h at 30 ◦C with shaking at 120 rev./min.
For plasmid DNA extraction from yeast, a modification of the
GenEluteTM Plasmid Miniprep Kit (Sigma–Aldrich) was used.
Briefly, cells were resuspended in 225 μl of resuspension buffer
and 100 μl of acid-washed glass beads (0.5 mm) and 225 μl of
lysis buffer were added. Cells were vortex-mixed for 30–40 min
and left to stand at 4 ◦C for 10 min, before collecting 400 μl
of cell lysate and proceeding according to the manufacturer’s
instructions. Plasmids were then amplified in Escherichia coli and
sequenced. For tobacco transient expression studies, alis5 mutant
sequences were amplified by PCR using primers oli4091 and
oli4092, and cloned into the pENTRTM/D-TOPO® vector using
c© 2016 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.
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the pENTRTM/D-TOPO® cloning kit (Invitrogen). alis5 mutant
versions were then transferred into plant binary plasmid pMDC32
[32] or pEarleyGate 101 [33] using the Gateway® technology.
Constructs in pEarleyGate 101 contain the alis5 DNA sequences
out of frame with respect to YFP resulting in untagged proteins.





noyl-sn-glycero-3-phosphoethanolamine and NBD-PS {1-palmi-
toyl-2-[6-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)-amino]hexanoyl-
sn-glycero-3-phosphoserine} (Avanti Polar Lipids) stocks
(4 mM) were prepared in DMSO. NBD-lipid uptake experiments
were performed as described previously [24]. Flow cytometry
of NBD-labelled cells was performed on a Becton Dickinson
FACSCalibur flow cytometer (BD Immunocytometry Systems)
equipped with an argon laser and Cell Quest software (BD
Biosciences). Before analysis 107 cells were labelled with 1 μl
of 1 mg/ml PI (propidium iodide) for staining of non-viable
cells. A total of 20000 cells were analysed without gating
during the acquisition. Viable cells were selected on the basis of
forward/side-scatter gating and PI exclusion. NBD fluorescence
of living cells was plotted on a histogram and the geometric mean
fluorescence intensity was used for further statistical analysis.
Data analysis was performed using Cyflogic software (CyFlo).
Yeast membrane preparation and protein quantification
Yeast transformants were inoculated in 4 ml of SD medium and
grown at 28 ◦C with shaking at 140 rev./min. After 24 h, cells
were inoculated into 200 ml of SD medium and grown for 24 h
under the same conditions. Cells were harvested and induced for
protein expression in 1 litre of YPG medium at 24 ◦C with shaking
at 140 rev./min. After 18–19 h of induction, cells were collected
by centrifugation at 3000 g for 5 min at 4 ◦C and washed in 25 ml
of ice-cold water. After centrifugation, cells were resuspended
in 10 ml of lysis buffer [40 mM Hepes/NaOH, pH 7.5, 150 mM
NaCl, 26% (v/v) glycerol, 0.1 mM PMSF, 1 μg/ml aprotinin,
1 μg/ml leupeptin, 1 μg/ml pepstatin A, 5 μg/ml antipain and
157 μg/ml benzamidine HCl (Sigma–Aldrich)] and vortex-mixed
with glass beads (200 μm; Sigma–Aldrich). The cell lysate was
clarified by two consecutive centrifugation steps at 1000 g for
10 min at 4 ◦C and 10000 g for 15 min at 4 ◦C. Membranes
were subsequently collected by centrifugation at 125000 g for
1 h at 4 ◦C. Pellets were homogenized in 1.5 ml of S-buffer
(same as lysis buffer but containing 20% (v/v) glycerol) and
the protein concentration was measured spectrophotometrically
using a NanodropTM 1000 instrument (Thermo Fisher Scientific).
Total yeast membranes were snap-frozen in liquid nitrogen and
stored at − 80 ◦C.
Deglycosylation assays and free-cysteine PEGylation
For protein deglycosylation, yeast membranes were diluted to
2 mg of protein/ml in S-buffer supplemented with 0.1% (w/v)
DDM (n-dodecyl-β-maltoside) (Glycon Biochemicals). After a
5-min pre-incubation on ice, samples were incubated for 30 min
on ice in the absence or presence of 0.8 μl of PNGase F (peptide
N-glycosidase F) (New England Biolabs). For disulfide bond
analysis, total membranes were diluted to 3 mg of protein/ml
in S-buffer. Samples were incubated for 20 min at 37 ◦C with
DMSO or mPEG (methoxypolyethylene glycol-5000 maleimide)
(Sigma–Aldrich) added from a 10× stock solution in DMSO. For
both assays, the reaction was stopped by TCA (trichloroacetic
acid) precipitation [34] and samples were resuspended in 18 μl
of loading buffer before immunodetection of proteins.
Membrane protein solubilization and pull-down assays
Yeast membranes were diluted to 3 mg of protein/ml in S-buffer
supplemented with 0.8% (w/v) DDM. Samples were gently
shaken at 4 ◦C for 75 min and then cleared of insoluble material
by centrifugation at 100000 g for 1 h at 4 ◦C. Solubilized yeast
membranes were subjected to FLAG-affinity chromatography
to recover wild-type ALA2–ALIS5 or mutant ALA2–alis5
complexes. To this end, 200 μl of anti-FLAG® M2 Affinity Gel
(Sigma–Aldrich) were washed twice with W-buffer [same as S-
buffer but containing 2% (v/v) glycerol and 0.05% (w/v) DDM]
and subsequently mixed with 9 ml of the detergent-solubilized
membrane extract. After incubation with gentle shaking at 4 ◦C
for 18 h, the gel was washed three times with W-buffer. For protein
elution, the gel was incubated twice at 4 ◦C for 30 min with W-
buffer supplemented with 400 μg/ml FLAG® peptide (Sigma–
Aldrich). Eluates were pooled and concentrated to 250 μl using
VivaspinTM columns (GE Healthcare) with a molecular mass cut-
off of 30 kDa.
Protein immunodetection and quantification
Concentrated eluates from the FLAG purification and 60 μl
samples of the detergent-solubilized membranes (input controls)
were precipitated with TCA, and resuspended in 80 μl of loading
buffer [60 mM Tris/HCl, pH 6.8, 10 mM DTT, 2 mM EDTA,
0.75% (w/v) SDS and 2.6% (w/v) sucrose] for SDS/PAGE.
For total yeast membrane samples, 200 μg of total protein
was precipitated with TCA and resuspended in the same
amount of loading buffer. In all cases, samples (20 μl) in
loading buffer were subjected to electrophoretic separation
in denaturing SDS/PAGE gels (10% (w/v) acrylamide) and
transferred on to PVDF membranes for immunodetection [34].
ALA2 was probed with a polyclonal KLH (keyhole-limpet
haemocyanin)-conjugated antibody raised in rabbit using a 120-
day immunization protocol (Open Biosystems). This antibody
recognizes a peptide present at the C-terminal end of ALA2
with the amino acid sequence RRSFGPGTPFEFFQSQSR. Target
specificity of this antibody was validated by Western blotting
using total membranes from yeast bearing an empty vector, or
expressing HA (haemagglutinin)-tagged versions of ALA2 or
of the related Arabidopsis P4-ATPase ALA3 (Supplementary
Figure S1). Absence of cross-reaction with pre-immune
serum was also confirmed. FLAG-tagged ALIS5 and alis5
mutants were detected using monoclonal mouse antibody anti-
FLAG® M2 (Sigma–Aldrich). Polyclonal goat-anti-rabbit and
rabbit-anti-mouse secondary antibodies conjugated to alkaline
phosphatase (Dako) were used. All antibodies were employed
at a 1:5000 dilution except for anti-FLAG (1:1000 dilution).
Bands were visualized with the BCIP (5-bromo-4-chloroindol-
3-yl phosphate)/NBT (Nitro Blue Tetrazolium) Color Devel-
opment Substrate (Promega) according to the manufacturer’s
instructions.
For pull-down assays, purified wild-type ALA2–ALIS5 and
ALA2–alis5 mutant complexes were run in parallel. For each
complex, an input control of the solubilized membrane fraction
used as starting material for purification was included in the
same gel. Western blots were scanned after development, and
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band intensity was quantified using ImageJ software (NIH).
The intensity of the ALA2 band in each purified complex was
normalized to the intensity of the ALA2 band in the corresponding
input control with solubilized membranes. The same procedure
was used to normalize the recovery of wild-type and mutant
ALIS5 versions. Then, the ratio between the normalized ALA2
and wild-type ALIS5 signals was calculated and set to 1 as a
reference. The ratio between the normalized ALA2 and alis5
signals was similarly calculated and referred to the wild-type
value. Results are means for two independent solubilization
experiments.
ATPase activity assays
Purified samples from pull-down assays (6.8 μl) supplemented
with 5 mM NaN3were incubated for 20 min at room temperature
with 0.32 mg/ml POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine) or a mixture of POPC with POPS (1-
palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine) (7:3, v/v) in
the presence or absence of 1 mM sodium orthovanadate (Sigma–
Aldrich). All lipids were purchased from Avanti Polar Lipids.
ATPase activity assays were performed in 50 μl reaction mixtures
containing 50 mM Hepes (pH 7.5), 100 mM NaCl, 50 mM
KCl, 10 mM MgCl2 and 4 mM Na2ATP (Sigma–Aldrich). After
incubation at 37 ◦C for 45 min, the reaction was stopped by
dilution with 150 μl of phosphate-free water. Released inorganic
phosphate was then detected using a Malachite Green assay [3].
Briefly, to samples from the ATPase assay, 150 μl of PiA solution
[two volumes of 7.8% (v/v) H2SO4 + one volume of 0.1 M
Na2MoO4], 150 μl of PiB solution [0.4 mM Malachite Green dye
(Sigma–Aldrich) in 1% (w/v) poly(vinyl alcohol)] and 500 μl
of 7.8% (v/v) H2SO4 were added consecutively. After 30 min of
incubation at room temperature in the dark, the absorbance was
measured at 630 nm. The amount of released inorganic phosphate
was calculated on the basis of KH2PO4 standards. Results are
means for two independent solubilization experiments.
Transient expression in tobacco epidermal leaf cells and confocal
microscopy
Agrobacterium tumefaciens strain C58C1 [35] was transformed
by electroporation, and transformants were selected on LB plates
[1.5% (w/v) agar, 1.0% (w/v) tryptone, 0.5% (w/v) yeast
extract and 0.5% (w/v) NaCl] supplemented with 25 μg/ml
gentamicin and 50 μg/ml kanamycin. Transient expression in
tobacco epidermal cells was carried out as described in [36]
using 3-week-old Nicotiana benthamiana plants. To facilitate
high expression of recombinant proteins, Agrobacterium strains
carrying the different constructs were co-infiltrated with a strain
carrying the p19 gene encoding the viral p19 protein that
specifically inhibits plant post-transcriptional gene silencing [37].
The concentration of each Agrobacterium strain in the mixture
was adjusted to a D600 of 0.03. Cells were visualized 3–4 days
after infiltration using a Leica TCS SP2/MP or SP5 II spectral
confocal laser-scanning microscope with a ×63 1.2 numerical
aperture water-immersion objective as described previously [24].
Protein sequence alignment
Sequences were aligned using T-Coffee software [38]. Accession
numbers were: A. thaliana, ALIS1 (Q9LTW0), ALIS3 (Q9SLK2)
and ALIS5 (Q8L8W0); human, CDC50A (Q9NV96) and
CDC50B (Q3MIR4); S. cerevisiae, Cdc50p (P25656), Crf1p
(P53740) and Lem3p (P42838); L. infantum, LiRos1 (A4IBN0),
LiRos2 (A4HU24), LiRos3 (A4I7N1); and C. elegans, CHAT-1
(H2L0H3).
Sequence-based prediction of post-translationally modified
residues
Post-translationally modified residues in the ALIS5 protein
sequence were predicted through online prediction servers.
N-glycosylation was examined using the NetNGlyc 1.0 Server
at http://www.cbs.dtu.dk/services/. The presence of putative
disulfide bonds was analysed using the DiANNA 1.1 web server
(http://clavius.bc.edu/∼clotelab/DiANNA/), the CYSPRED Pre-
dictor (http://gpcr.biocomp.unibo.it/cgi/predictors/cyspred/pred_
cyspredcgi.cgi) and the SCRATCH protein predictor
(http://scratch.proteomics.ics.uci.edu/).
RESULTS
Prediction of post-translationally modified residues in the ALIS5
ectodomain
Sequence-based prediction suggested that the ectodomain of the
plant P4-ATPase β-subunit ALIS5 contains 233 amino acids
with two putative N-glycosylation sites (Asn181 and Asn231)
and four cysteine residues (Cys86, Cys107, Cys158 and Cys172)
(Figure 1). Alignment of the ALIS5 amino acid sequence with
those of selected β-subunits from plants, humans, C. elegans,
yeast and Leishmania parasites revealed that glycosylation of
the ectodomain at Asn231 is specific for ALIS5 (Figure 1). In
contrast, glycosylation site Asn181 resides in a sequence motif
(PCGLVAWSLFND) that is highly conserved among all Cdc50
proteins tested, and which also contains a conserved cysteine
residue (Cys172 in ALIS5). Of the other three cysteine residues
in the ALIS5 ectodomain, Cys158 is conserved in all tested β-
subunits except L. infantum LiRos1, whereas Cys107 is not present
in any Leishmania β-subunit. In contrast, Cys86 is characteristic
of all three Arabidopsis β-subunits. Notably, this cysteine residue
is located in a poorly conserved region in which cysteine residues
can be found for almost all organisms analysed, but at different
positions. The ALIS5 ectodomain sequence was run through
several online prediction servers to identify putative disulfide
bonds with contradictory results.
Mapping N-glycosylation sites in the ALIS5 ectodomain
To determine whether Asn181 and Asn231 undergo N-glycosylation
in vivo, mutant versions of ALIS5 bearing single or double point
mutations were generated by replacing these asparagine residues
with glutamine (N231Q, N181Q and N231Q/N181Q). Next, we
co-expressed the different alis5 variants with the ALA2 catalytic
subunit in a yeast strain deleted in three out of five endogenous
P4-ATPases (Δdnf1Δdnf2Δdrs2) [28], taking advantage of the
fact that N-glycosylation initiation in the ER is conserved in all
eukaryotic cells. Thus, although the final glycan composition is
different for a protein expressed in yeast or plants, N-glycosylation
takes place at the same positions [39]. Western blot analysis of
total yeast membranes demonstrated that mutation of the putative
glycosylation sites does not significantly affect protein expression
(Figure 2A). Western blot analysis showed two bands of different
mobility (approximately 37.5 and 40 kDa) for the wild-type
version of ALIS5 (Figure 2B). The high-intensity 40 kDa band
(band I) corresponded to a glycosylated form of the protein,
as demonstrated by the loss of signal intensity for this band
after glycosidase incubation. The low-intensity 37.5 kDa band
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Figure 1 Alignment of the ectodomain of Ccd50 proteins
Amino acid sequences from Cdc50 proteins described to interact with P4-ATPases in A. thaliana (ALIS, ALIS3 and ALIS5), humans (CDC50A and CDC50B), C. elegans (CHAT-1), S. cerevisiae
(Cdc50p, Lem3p and Crf1p) and L. infantum (LiRos1, LiRos2 and LiRos3) were aligned using T-Coffee. Accession numbers are listed in the Materials and methods section. Only the part of the
alignment corresponding to the ALIS5 ectodomain is shown. Black boxes indicate highly conserved cysteine residues (C). N-glycosylated residues (N) are shadowed in grey and marked by an arrow.
The ALIS5 transmembrane domains (TM) are indicated by grey boxes. All position numbers are given with respect to ALIS5.
(band III) was insensitive to glycosidase digestion even after
60 min of treatment (results not shown), and thus corresponded
to non-glycosylated ALIS5. The reduction in signal intensity for
the high-molecular-mass band I after glycosidase digestion was
accompanied by an increase in the signal for the non-glycosylated
band III and the appearance of an intermediate-molecular-mass
band (band II), suggesting that more than one glycosylation site
is present in the protein. In line with this notion, both alis5
single mutants (N231Q and N181Q) lacked band I, but showed
the intermediate-molecular-mass band II, which was readily
deglycosylated by glycosidase treatment. Simultaneous mutation
of both predicted glycosylation sites resulted in an intense band
corresponding to the non-glycosylated form of ALIS5 (band III)
and a weak band of higher molecular mass that is insensitive to
PNGase F treatment. Collectively, these results demonstrate that
Asn181 and Asn231 are the only N-glycosylation sites present in
ALIS5.
N-glycosylation of ALIS5 is important for functionality and stability
of the P4-ATPase complex
Next, the effect of eliminating N-glycosylation in the ALIS5
ectodomain on the function of the P4-ATPase complex was
investigated. As a first approach, complementation assays on
plates containing cytolytic peptides were performed. The lipid-
uptake defect of Δdnf1Δdnf2Δdrs2 yeast cells results in PS
and PE (phosphatidylethanolamine) exposure to the outer leaflet
of the plasma membrane. Such abnormal lipid distribution can
be detected using the toxic peptides duramycin and papuamide
A, which induce lysis of the yeast cells upon binding to cell
surface-exposed PE and PS respectively [40,41]. Co-expression
of an active P4-ATPase complex in the Δdnf1Δdnf2Δdrs2
strain recovers membrane lipid asymmetry and thus results
in lower sensitivity to the cytotoxic peptides [23,24]. Co-
expression of wild-type ALIS5 with ALA2 recovered growth in
c© 2016 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.
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Figure 2 N-glycosylation of the ALIS5 ectodomain is essential for functionality of the P4-ATPase complex
Yeast Δdnf1Δdnf2Δdrs2 mutant cells were transformed with galactose-inducible plasmids expressing ALA2 together with FLAG-tagged ALIS5 or alis5 N-glycosylation mutants. (A) Western blot
analysis of total yeast membranes. ALA2 and ALIS5 were detected using anti-ALA2 and anti-FLAG antibodies respectively. Molecular masses are indicated in kDa. (B) Yeast membranes were incubated
for 30 min in the presence ( + ) or absence ( − ) of PNGase F and analysed by immunoblotting. The position of the 40 kDa band is indicated. (C) Cells were spotted on to galactose-containing plates
(Induced) in the presence or absence ( − ) of lipid-binding cytotoxic peptides, as indicated. Cells transformed with an empty vector (e.v.) served as a negative control. (D) NBD-lipid-uptake assays.
Results are normalized to an empty vector (e.v.) control and expressed as means +− S.E.M. from three independent experiments. 100 % corresponds to 64 +− 3 for NBD-PC, 53 +− 4 for NBD-PE and
122 +− 7 for NBD-PS. (E) Interaction of ALA2 with wild-type ALIS5 or the indicated alis5 mutants monitored by pull-down assay. Recovery of ALA2 was determined from the quantification of at least
two independent experiments as described in the Materials and methods section. Results are means +− S.D.
the presence of papuamide A, but not duramycin (Figure 2C),
confirming functional PS transport [24]. Analysis of glycosylation
mutants showed that only alis5N231Q was able to promote
growth on papuamide A, although at a reduced level compared
with wild-type ALIS5 (Figure 2C). These differences in yeast
growth could not be related to variations in expression levels
between wild-type ALA2–ALIS5 and the different ALA2–alis5
mutant complexes (Figure 2A), suggesting that N-glycosylation,
especially at Asn181, is crucial for ALA2–ALIS5 complex
functionality.
As a second approach, uptake of fluorescent NBD-
phospholipids at the plasma membrane was measured. This
assay confirmed that the ALA2–ALIS5 complex internalizes
labelled PS but not PE or PC (phosphatidylcholine) [24]
(Figure 2D). Disruption of N-glycosylation at Asp181 (alis5N181Q
and alis5N231Q/N181Q) abolished NBD-PS transport. Even
though the ALA2–alis5N231Q complex partially complemented
the defect in natural PS transport in Δdnf1Δdnf2Δdrs2 cells
(Figure 2C), it was unable to promote NBD-PS transport at
the plasma membrane (Figure 2D). Conceivably, the ALA2–
alis5N231Q complex localizes to internal membranes, and
thereby helps to generate PS membrane asymmetry along the
secretory pathway towards the plasma membrane. Attempts to
estimate the amount of ALA2–ALIS5 complex at the plasma
membrane level were unsuccessful.
The ability of alis5 glycosylation mutants to form stable
complexes with ALA2 was assessed by performing pull-down
assays where detergent-solubilized yeast membranes expressing
ALA2 and FLAG-tagged versions of wild-type ALIS5 or
alis5 mutants were subjected to FLAG-affinity chromatography
(Figure 2E). Although disruption of N-glycosylation at Asn231 had
no impact on the recovery of ALA2 in the eluate, Asn181 mutants
showed reduced recovery of the catalytic subunit, suggesting that
N-glycosylation of this residue is essential for stable association of
the complex. A PS-dependent vanadate-sensitive ATPase activity
could only be measured for complexes containing wild-type
ALIS5 (0.096 +− 0.074 nmol of released phosphate/min) and
alis5N231Q (0.103 +− 0.041 nmol of released phosphate/min),
but not for alis5 mutants modified in the conserved Asn181
residue. However, we did not obtain enough material to reliably
normalize the activity values to the amount of ALA2 present
in the samples. It therefore cannot be ruled out that lack of
ATPase activity for alis5N181Q mutants is due to poor ALA2
recovery.
c© 2016 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.
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N-glycosylation of the β-subunit is essential for ALA2–ALIS5
complex trafficking in planta
To study whether the mutants are able to support trafficking of
the complex in planta, we used a tobacco transient expression
system. In this system, co-expression of ALA2 with wild-type
ALIS5 results in exit of the transporter complex from the ER and
its localization to vesicular structures (Figure 3). These structures
were previously demonstrated to correspond to an enlarged pre-
vacuolar compartment by co-localization with a marker protein
specific for this compartment [24]. Co-expression of GFP–
ALA2 in combination with untagged ALIS5 or alis5N231Q
promoted localization of the fluorescently tagged P4-ATPase to
enlarged pre-vacuolar compartment structures, although a clear
ER signal was detected for the glycosylation mutant. In contrast,
when co-expressed with alis5N181Q or alis5N231Q/N181Q,
ALA2 was retained in ER-like structures and did not reach the pre-
vacuolar compartment. To confirm that lack of ER exit is not due
to lack of expression of a β-subunit, we generated C-terminally
YFP-tagged versions of the alis5 mutants and co-expressed them
in tobacco together with GFP–ALA2 (Supplementary Figure
S2). In all cases, YFP fluorescence could be readily detected
and co-localized with the signal for GFP–ALA2, confirming
that glycosylation of Asn181 is essential for P4-ATPase complex
trafficking.
Mapping disulfide bonds in the ALIS5 ectodomain
To identify putative disulfide bonds between the four cysteine
residues (Cys86, Cys107, Cys158 and Cys172) in the ALIS5
ectodomain, single alanine substitutions of each cysteine
residue (C86A, C107A, C158A and C172A) were generated
and expressed together with ALA2 in the Δdnf1Δdnf2Δdrs2
yeast strain. Western blot analysis of total yeast membranes
demonstrated that the expression levels of ALA2 and ALIS5
are unaffected by mutation of the cysteine residues (Figure 4A).
Yeast membranes containing ALA2 and wild-type ALIS5 or alis5
cysteine mutants were treated with mPEG, a maleimide-functional
PEG molecule able to covalently bind to free cysteine residues
[25]. Western blot analysis revealed a 15 kDa increase in mobility
for wild-type ALIS5 after mPEG treatment, corresponding to
binding of mPEG to a single cysteine residue (Figure 4B). An
alis5C mutant lacking all cysteine residues in the ectodomain
showed the same shift in mobility, demonstrating that this single
free cysteine residue corresponds to residue 41 present in the
cytosolic N-terminus of ALIS5. These results also suggest that
all four cysteine residues in the ALIS5 ectodomain are involved
in disulfide bond formation and are therefore not available for
mPEG labelling. Thus single mutation of any of these cysteine
residues would generate an additional free cysteine residue and
allow the protein to bind two molecules of mPEG, resulting in an
additional shift in the apparent molecular mass of the subunit.
However, the C86A and C107A mutations did not result in
a band of slower mobility, suggesting that these two residues
are not accessible for mPEG labelling due to steric/structural
constraints or to their involvement in intermolecular disulfide
bonds. In contrast, C158A or C172A point mutations resulted
in mPEG adducts with an additional mobility shift compared
with wild-type ALIS5 or alis5C (Figure 4B). Interestingly,
the mobility shift was found to be different for each of the
mutants after mPEG treatment. This was also the case for double
alis5C107A/C172A and alis5C107A/C158A mutants. Owing to
their proximity, it is conceivable that generation of a highly
reactive thiol group at position 172 may affect N-glycan extension
at the glycosylated Asn181, resulting in a smaller molecule with
Figure 3 N-glycosylation of Asn181 is essential for P4-ATPase complex
trafficking
An N-terminal fusion of ALA2 to GFP (GFP–ALA2) was expressed in tobacco leaf epidermal
cells in combination with untagged ALIS5 or the indicated alis5 N-glycosylation mutants before
imaging by confocal microscopy. Representative images of one experiment out of three are
shown. Arrowheads indicate pre-vacuolar compartment structures. Scale bar, 10 μm.
higher electrophoretic mobility. Our results suggest that the
conserved residues Cys158 and Cys172 form an intramolecular
disulfide bond in the ectodomain of ALIS5, whereas Cys86 and
Cys107 are either not accessible to mPEG labelling or are involved
in intermolecular disulfide bonds.
ALIS5 Cys86 and Cys107 are important for functionality and stability
of the P4-ATPase complex
We next investigated the role of disulfide bond formation
on functionality of the P4-ATPase complex, by testing the
ability of ALA2–alis5 complexes to support growth of the
Δdnf1Δdnf2Δdrs2 yeast strain on papuamide A-containing
plates. Co-expression of wild-type ALIS5 with ALA2 recovered
growth in the presence of papuamide A (Figure 4C). The same
was the case for alis5 mutants in Cys158 or Cys172, whereas
substitution of either Cys86 or Cys107 failed to support yeast
growth. Intriguingly, cells expressing alis5 mutants containing
C86A or C107A substitutions presented a general reduction in
growth on galactose plates compared with Δdnf1Δdnf2Δdrs2
c© 2016 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.
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Figure 4 Mutation of Cys86 and/or Cys107 in ALIS5 disrupts complex association with ALA2
Yeast Δdnf1Δdnf2Δdrs2 mutant cells were transformed with galactose-inducible plasmids expressing ALA2 together with wild-type ALIS5 or the indicated alis5 mutants carrying cysteine-to-alanine
mutations in their ectodomain. (A) Western blot analysis of total yeast membranes. ALA2 and ALIS5 were detected using anti-ALA2 and anti-FLAG antibodies respectively. Molecular masses are
indicated in kDa. (B) Yeast membranes were isolated, incubated in the presence ( + ) or absence ( − ) of mPEG and subsequently analysed by Western blotting using anti-FLAG antibody. Arrowheads
indicate adducts of ALIS5 bound to one (single arrowheads) or two (double arrowhead) molecules of mPEG. Molecular masses are indicated in kDa. (C) Cells were spotted on to galactose-containing
plates (Induced) in the presence or absence ( − ) of lipid-binding cytotoxic peptides, as indicated. Cells transformed with an empty vector (e.v.) served as a negative control. (D) NBD-lipid-uptake
assays. Results are normalized to empty vector (e.v.) control and expressed as means +− S.D. from at least two independent experiments. 100 % corresponds to 5.8 +− 1.0 for NBD-PC, 5.5 +− 0.6 for
NBD-PE and 6.6 +− 0.9 for NBD-PS. (E) Interaction of ALA2 with wild-type ALIS5 or the indicated alis5 mutants monitored by pull-down. Recovery of ALA2 was determined from the quantification of
at least two independent experiments as described in the Material and methods section. Results are means +− S.D.
cells harbouring an empty vector. This might indicate that these
point mutations result in release of a reactive cysteine residue with
toxic effects for the cell.
Next, we measured NBD-lipid translocation across the plasma
membrane. In line with the growth assay, mutation of cysteine
residues involved in confirmed disulfide bond formation (C158A
and/or C172A) did not affect NBD-PS lipid transport by the
complex (Figure 4D). Surprisingly, albeit to a lesser extent
compared with wild-type ALIS5, all alis5 mutants containing
C86A or C107A substitutions were still able to transport NBD-
PS across the yeast plasma membrane in the presence of
ALA2, indicating that these mutations still allow to some extent
trafficking of functional complexes to the yeast plasma membrane.
Pull-down assays demonstrated that disruption of the disulfide
bond formed between the heavily conserved Cys158 and Cys172
residues had no impact on complex association (Figure 4E). In
contrast, alis5 mutants containing an alanine substitution for Cys86
and/or Cys107 showed a reduction in the recovery of the ALA2
catalytic subunit with respect to wild-type ALIS5, suggesting that
mutation of these residues affects the capacity of the β-subunit to
interact with the P4-ATPase.
Cysteine-to-alanine substitutions in the ALIS5 ectodomain do not
affect P4-ATPase complex localization in planta
Localization of the P4-ATPase complexes was tested by transient
expression in tobacco epidermal cells. None of the alis5 cysteine
mutations prevented trafficking of ALA2 to the pre-vacuolar
compartment (Figure 5). Together with the results of our pull-
down assays, these results suggest that the disulfide bond formed
between the two evolutionarily conserved cysteine residues in
the ALIS5 ectodomain is not essential for association with the
catalytic subunit, trafficking or activity of the P4-ATPase complex.
c© 2016 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.
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Figure 5 Cysteine residues in the ALIS5 ectodomain are not essential for
ALA2 intracellular trafficking
An N-terminal fusion of ALA2 to GFP (GFP–ALA2) was expressed in tobacco leaf epidermal
cells in combination with untagged ALIS5 or alis5 cysteine-to-alanine mutants before imaging
by confocal microscopy. Representative images of one experiment out of three are shown.
Arrowheads indicate pre-vacuolar compartment structures. Scale bar, 10 μm.
In contrast, Cys86 and Cys107 are required for stable complex
association, although mutants of these residues are still able to
support, to some extent, trafficking of the P4-ATPase complex
and P4-ATPase lipid translocation.
DISCUSSION
In the present study, we verified the presence of post-
translationally modified residues in the plant P4-ATPase β-
subunit ALIS5, and analysed further the impact of site-directed
mutagenesis of these residues in complex assembly, trafficking
and functionality. First, we focused on the two predicted
glycosylation sites for this protein. N-glycosylation of the
conserved residue Asn181 in the ALIS5 ectodomain plays an
essential role in complex formation and ER exit. In contrast with
our results, mutation of this residue in the human P4-ATPase β-
subunit CDC50A results in lower expression levels for the rod
outer segment P4-ATPase ATP8A2 expressed in HEK (human
embryonic kidney)-293 cells [21], but does not affect complex
formation, as ATP8A2 can be co-immunoprecipitated with the
β-subunit even after elimination of all N-glycosylation sites in
CDC50A. In the unicellular parasite L. infantum, modification
of the same conserved N-glycosylated residue in the β-subunit
LiRos3 had no significant effect on the amount of P4-ATPase
complex that reached the parasite plasma membrane [27]. This
would suggest that, as for the human protein, elimination of
glycosylation in the conserved residue does not affect protein
interaction within the complex, which is required for ER exit.
Interestingly, both ATP8A2 and the Leishmania P4-ATPase LiMT
specifically interact with CDC50A and LiRos3 respectively, and
they do not associate with other β-subunits [11,20]. In contrast, all
Arabidopsis P4-ATPases characterized to date, including ALA2,
are able to interact with any of three different ALIS β-subunits
for ER exit [22–24,42]. Although the results obtained in the
present study might reflect a plant-specific event, a number of
human P4-ATPases are also capable of interacting with several
CDC50 proteins [7]. An intriguing possibility to consider is that
post-translational modification of the conserved N-glycosylated
residue might serve different functions when the β-subunit forms
complexes with promiscuous or monogamous members of the
P4-ATPase family.
Mutagenesis of the four cysteine residues present in the
ectodomain of ALIS5 demonstrated the existence of at least
one disulfide bond (Cys158–Cys172), formed between two cysteine
residues which seem to be strictly conserved in a number
of organisms. Disruption of this disulfide bond in ALIS5
does not have any detrimental effects on P4-ATPase complex
interaction, trafficking or lipid translocation across the yeast
plasma membrane. This was not expected, as mutation of any of
the conserved cysteine residues forming this bond in the yeast β-
subunit Lem3p results in a reduction of NBD-lipid internalization
at the plasma membrane level [25]. In contrast, mutation of Cys86
and/or Cys107 in ALIS5 had dramatic effects on stable association
of the P4-ATPase complex, as could be inferred from pull-down
assays. However, ALA2 was still capable of leaving the ER and
making it to the pre-vacuolar compartment when expressed in
plant cells together with the alis5C86A and alis5C107A mutants.
This suggests that the proteins can still interact at the ER level,
but the strength of the interaction within the complex is greatly
reduced. Similar results were obtained for yeast Lem3p after
mutation of the corresponding cysteine residues [25]. Notably,
yeast Lem3p specifically interacts with the plasma membrane P4-
ATPases Dnf1p and Dnf2p, and these ATPases do not interact
with any other β-subunit [19]. Taken together, our results suggest
that the presence of two disulfide bonds within the P4-ATPase
β-subunit, one of them located within the first third of the
ectodomain, is essential to maintain its functionality. Although
the role of this first disulfide bond seems to be conserved between
β-subunits for monogamous and promiscuous P4-ATPases, the
heavily conserved disulfide bond has evolved slightly different
functions.
In conclusion, we have demonstrated the presence of two
N-glycosylation sites and at least one disulfide bond in the
ectodomain of the plant P4-ATPase β-subunit ALIS5. In contrast
with other organisms, elimination of a conserved N-glycosylation
site and non-conserved cysteine residues in ALIS5 affects
complex formation, whereas elimination of a conserved disulfide
c© 2016 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.
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bond does not have any consequence for P4-ATPase complex
functionality. The ALA2 P4-ATPase analysed in the present
study is a promiscuous protein that interacts with several β-
subunits in contrast with previously studied P4-ATPases from
other organisms. Although we cannot rule out the possibility
that the observed behaviour for the ALA2–ALIS5 complex in
the yeast expression system might differ when assayed in the
plant native environment, our results suggest that conserved
post-translational modifications in the β-subunit might have
different roles depending on the promiscuous nature of the
interacting P4-ATPase. It would therefore be interesting to
investigate whether promiscuous human P4-ATPases react to
post-translational modifications in the β-subunit in the same way
as the previously characterized monogamous ATP8A2.
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